Veritas Vision System will help address three critical areas such as patient safety, surgeon efficiency and comfort
Johnson & Johnson Vision, part of the Johnson & Johnson Medical Devices Companies, has introduced a next-generation cataract surgery system called Veritas Vision System.
The next-generation phacoemulsification (phaco) system has been developed to address three critical areas such as patient safety, surgeon efficiency and comfort.
Phacoemulsificatiom is a common cataract surgery that enables surgeons to emulsify and remove the eye’s internal lens when it turns cloudy from cataracts.
The Veritas Vision System features hybrid fluidics technology that helps to minimise ost-occlusion surge to protect intraocular structures and offer better chamber stability.
The system also uses intelligent occlusion sensing technologies to automatically respond to occlusions to preserve a stable chamber even in dense cataract cases.
Johnson & Johnson has built the system using the Whitestar technology combined with elliptical tip movement for smooth cutting even in dense or advanced cataracts.
Veritas consists of dual pump system that helps to access both peristaltic and venturi pumps with on-demand transition between the two at every step.
Johnson & Johnson Vision surgical president worldwide president Warren Foust said: “On top of providing a safe and stable procedure for cataract patients, we wanted to also offer a more efficient and comfortable phacoemulsification experience for surgeons, especially knowing most will perform multiple cataract surgeries every day.
“Our VERITAS Vision System delivers high-performing, reliable tools for a smooth, effective cataract surgery for patients while also prioritizing surgeon well-being.”
The company is currently offering Veritas Vision System for ophthalmologists across the US, Europe and select markets in the Asia Pacific region.